Buy Arbutus Biopharma Stock | ABUS Stock Price & Latest News | Public
ABUS

Arbutus Biopharma

$0.00 (0.00%)Today
    Small Market Cap

    About ABUS

    Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The full company name is Arbutus Biopharma Corp...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.31
    -0.46
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.22

    Actual EPS
    Q3 2020

    Stats

    Market Cap$260,33M
    Volume88,57k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.02
    1 Year Low$0.82
    Open$3.00
    High$3.19
    Low$2.98

    Buy any stock with any amount of money.

    Download the App
    Download the app